The aim of the consortium is to help organ-on-a-chip technology achieve a breakthrough on a social and economic level through coordinated action. Organ-on-chips are miniature organs based on concepts of microfluidics and microtechnology. This technology already offers new possibilities for drug discovery and is an alternative to conventional animal experiments. Organ-on-chips can also be used in personalised medicine or safety pharmacology. The EU will invest 0.5 million euros over the next two years in the ORgan-on-CHip In Development (ORCHID) project.
Further information and source (in German):
https://www.igb.fraunhofer.de/de/presse-medien/presseinformationen/2017/ORCHID.html